Hunan Jingfeng Pharmaceutical (000908) — Cash Flow-to-Debt Ratio
Hunan Jingfeng Pharmaceutical (000908) has a Cash Flow-to-Debt Ratio of 0.14x as of September 2025, meaning its operating cash flow of CN¥125.78 Million could theoretically repay 0% of its total liabilities (CN¥915.74 Million) in one year. See free cash flow generation of Hunan Jingfeng Pharmaceutical to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hunan Jingfeng Pharmaceutical Cash Flow-to-Debt Ratio (1999–2024)
Historical debt coverage capacity for Hunan Jingfeng Pharmaceutical across 26 annual periods. Also explore 000908 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Hunan Jingfeng Pharmaceutical (1999–2024)
Year-by-year debt coverage analysis for Hunan Jingfeng Pharmaceutical. For market capitalisation and broader financial context, see Hunan Jingfeng Pharmaceutical market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.01x | CN¥-5.55 Million | CN¥955.11 Million | ▼ -120.1% |
| 2023 | 0.03x | CN¥35.06 Million | CN¥1.21 Billion | ▼ -70.6% |
| 2022 | 0.10x | CN¥123.27 Million | CN¥1.25 Billion | ▲ +16.3% |
| 2021 | 0.08x | CN¥123.83 Million | CN¥1.46 Billion | ▲ +163.9% |
| 2020 | -0.13x | CN¥-271.68 Million | CN¥2.05 Billion | ▼ -981.6% |
| 2019 | 0.02x | CN¥36.17 Million | CN¥2.41 Billion | ▼ -89.9% |
| 2018 | 0.15x | CN¥350.94 Million | CN¥2.37 Billion | ▲ +122.0% |
| 2017 | 0.07x | CN¥151.65 Million | CN¥2.27 Billion | ▲ +1267.6% |
| 2016 | 0.00x | CN¥12.32 Million | CN¥2.52 Billion | ▼ -93.7% |
| 2015 | 0.08x | CN¥92.37 Million | CN¥1.19 Billion | ▼ -65.5% |
| 2014 | 0.22x | CN¥205.93 Million | CN¥919.76 Million | ▲ +2256.1% |
| 2013 | -0.01x | CN¥-3.44 Million | CN¥331.47 Million | ▼ -1371.2% |
| 2012 | 0.00x | CN¥351.50K | CN¥430.29 Million | ▲ +105.0% |
| 2011 | -0.02x | CN¥-6.87 Million | CN¥420.66 Million | ▲ +55.6% |
| 2010 | -0.04x | CN¥-15.21 Million | CN¥413.53 Million | ▼ -111.8% |
| 2009 | -0.02x | CN¥-11.88 Million | CN¥684.14 Million | ▼ -136.4% |
| 2008 | 0.05x | CN¥31.02 Million | CN¥650.60 Million | ▼ -56.5% |
| 2007 | 0.11x | CN¥52.26 Million | CN¥477.43 Million | ▼ -8.1% |
| 2006 | 0.12x | CN¥57.90 Million | CN¥486.08 Million | ▲ +202.2% |
| 2005 | -0.12x | CN¥-59.49 Million | CN¥510.48 Million | ▲ +59.0% |
| 2004 | -0.28x | CN¥-156.37 Million | CN¥550.11 Million | ▼ -811.7% |
| 2003 | 0.04x | CN¥22.51 Million | CN¥563.64 Million | ▼ -21.9% |
| 2002 | 0.05x | CN¥17.59 Million | CN¥343.98 Million | ▼ -79.5% |
| 2001 | 0.25x | CN¥30.50 Million | CN¥122.47 Million | ▲ +296.2% |
| 2000 | -0.13x | CN¥-25.05 Million | CN¥197.38 Million | ▼ -292.2% |
| 1999 | 0.07x | CN¥13.64 Million | CN¥206.51 Million | — |